We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+2.15%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$843M
AUM Growth
+$92.2M
Cap. Flow
+$126M
Cap. Flow %
14.96%
Top 10 Hldgs %
33.86%
Holding
109
New
20
Increased
44
Reduced
26
Closed
18

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$21.4M
2
CVS icon
CVS Health
CVS
+$19M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$18.7M
4
RVTY icon
Revvity
RVTY
+$16.1M
5
UNH icon
UnitedHealth
UNH
+$15.4M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$27.5M
2
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$20.3M
3
ABT icon
Abbott
ABT
+$20M
4
GILD icon
Gilead Sciences
GILD
+$16.1M
5
BSX icon
Boston Scientific
BSX
+$11.2M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OSCR icon
101
Oscar Health
OSCR
$9.14B
– –
-125,000
Closed -$1.68M
RVPH
102
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
– –
-25,714
Closed -$931K
STRO icon
103
Sutro Biopharma
STRO
$353M
– –
-172,793
Closed -$3.18M
TEVA icon
104
Teva Pharmaceuticals
TEVA
$42.8B
– –
-196,805
Closed -$4.34M
THRD
105
DELISTED
Third Harmonic Bio
THRD
– –
-86,707
Closed -$892K
CLYM
106
Climb Bio
CLYM
$827M
– –
-290,491
Closed -$523K
CBLL
107
CeriBell Inc
CBLL
$879M
– –
-32,002
Closed -$828K
ITCI
108
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-243,123
Closed -$20.3M
NARI
109
DELISTED
Inari Medical, Inc. Common Stock
NARI
– –
-77,223
Closed -$3.94M
1 2 3 4
5

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Parkman Healthcare Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Parkman Healthcare Partners held 109 positions worth $843M, up 12% from $751M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Parkman Healthcare Partners deployed $126M of net new capital in Q1 2025, opening 20 new positions and adding to 44 existing holdings. Its largest new stake was Zimmer Biomet: 200,500 shares worth $22.7M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Verona Pharma, an estimated $27.5M trimmed.

  • Parkman Healthcare Partners's largest Q1 2025 buy was Zimmer Biomet: 200,500 shares worth $22.7M.
  • Parkman Healthcare Partners added most to CVS Health in Q1 2025, an estimated $19M increase.
  • Parkman Healthcare Partners's biggest Q1 2025 reduction was Verona Pharma, cutting an estimated $27.5M.
  • Parkman Healthcare Partners fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $20.3M.
  • Parkman Healthcare Partners's ten largest holdings make up 34% of its $843M portfolio in Q1 2025.
  • Parkman Healthcare Partners opened 20 new positions and closed 18 in Q1 2025.
  • Parkman Healthcare Partners's portfolio value rose 12% quarter-over-quarter to $843M.

Based on Parkman Healthcare Partners's 13F filing for Q1 2025, filed 15 May 2025.